Xu Zhao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Sentinel Lymph Node

Prognostic Factors

Radiation Therapy

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xinxin Rao, Xuanyi Wang, Kairui Jin, Yilan Yang, Xu Zhao, Zhe Pan, Weiluo Lv, Zhen Zhang, Li Zhang, Xiaoli Yu, Xiao-Mao Guo
Outcomes with and without postmastectomy radiotherapy for pT3N0-1M0 breast cancer: An institutional experience. Cancer medicine (2024)
Xinxin Rao, Xuanyi Wang, Kairui Jin, Yilan Yang, Xu Zhao, Zhe Pan, Weiluo Lv, Zhen Zhang, Li Zhang, Xiaoli Yu, Xiao-Mao Guo
Outcomes with and without postmastectomy radiotherapy for pT3N0-1M0 breast cancer: An institutional experience. Cancer medicine 13 (1) (2024)
Xinxin Rao, Xuanyi Wang, Kairui Jin, Yilan Yang, Xu Zhao, Zhe Pan, Weiluo Lv, Zhen Zhang, Li Zhang, Xiaoli Yu, Xiao-Mao Guo
Outcomes with and without postmastectomy radiotherapy for pT3N0-1M0 breast cancer: An institutional experience. Cancer medicine (2024)
Xu Zhao, Yilan Yang, Zhe Pan, Weiluo Lv, Xinxin Rao, Xuanyi Wang, Xiaoli Yu
Plateletcrit is predictive of clinical outcome and prognosis for early-stage breast cancer: A retrospective cohort study based on propensity score matching. Cancer medicine 13 (2) (2024)
Xu Zhao, Yilan Yang, Zhe Pan, Weiluo Lv, Xinxin Rao, Xuanyi Wang, Xiaoli Yu
Plateletcrit is predictive of clinical outcome and prognosis for early-stage breast cancer: A retrospective cohort study based on propensity score matching. Cancer medicine 13 (2) (2024)
Xu Zhao, Yilan Yang, Zhe Pan, Weiluo Lv, Xinxin Rao, Xuanyi Wang, Xiaoli Yu
Plateletcrit is predictive of clinical outcome and prognosis for early-stage breast cancer: A retrospective cohort study based on propensity score matching. Cancer medicine 13 (2) (2024)
Xinxin Rao, Xuanyi Wang, Kairui Jin, Yilan Yang, Xu Zhao, Zhe Pan, Weiluo Lv, Zhen Zhang, Li Zhang, Xiaoli Yu, Xiao-Mao Guo
Outcomes with and without postmastectomy radiotherapy for pT3N0-1M0 breast cancer: An institutional experience. Cancer medicine (2024)